Quality of Life of Patients With a History of Drug Allergy in Thailand
NCT ID: NCT01666470
Last Updated: 2019-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
306 participants
OBSERVATIONAL
2012-08-31
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis
NCT02271620
Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
NCT02000648
Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen
NCT03014661
Characteristics of Patients Diagnosed With NSAID Sensitivity in Thailand
NCT03849625
Comparison Between Local and Imported Skin Prick Testing Result of Rat and Mouse Allergen Extracts
NCT03645161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Drug allergy patients
Patients with a history of drug allergy in Thailand
Questionnaires
DrHy-Q (Thai version) and WHOQOL-BREF-THAI will be asked
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires
DrHy-Q (Thai version) and WHOQOL-BREF-THAI will be asked
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 18 years of age
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jettanong Klaewsongkram
Head of Division of Allergy and Clinical Immunology, Department of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jettanong Klaewsongkram, MD
Role: PRINCIPAL_INVESTIGATOR
Chulalongkorn University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Chulalongkorn University
Bangkok, , Thailand
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Reliability and validity of the Thai Drug Hypersensitivity Quality of Life Questionnaire: a multi-center study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Chula-ARC 001/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.